← Open Payments lookup

KIMBERLY RIVERA: Open Payments

NPI 1770152175 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$346 in 17 payments from 10 companies in 2025. Trend: 2023 $576 · 2024 $403 · 2025 $346

Food & beverage: $346
CompanyPaymentsAmount
Axsome Therapeutics, Inc.5$101
Indivior Inc.3$51
Otsuka America Pharmaceutical, Inc.2$49
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$31
Vanda Pharmaceuticals Inc.1$23
ABBVIE INC.1$22
Neurocrine BioSciences, Inc.1$21
E.R. Squibb & Sons, L.L.C.1$17
Gilead Sciences, Inc.1$17
Alkermes, Inc.1$14

Products named: Auvelity, SUBLOCADE, REXULTI, CAPLYTA, FANAPT, VRAYLAR, INGREZZA, COBENFY.

Industry payments across LA — which companies pay providers there.